These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 18615344)

  • 1. The history and future prospective of haplo-identical stem cell transplantation.
    Handgretinger R; Lang P
    Cytotherapy; 2008; 10(5):443-51. PubMed ID: 18615344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation.
    Ball LM; Lankester AC; Bredius RG; Fibbe WE; van Tol MJ; Egeler RM
    Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S35-8. PubMed ID: 15812528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease.
    Ho VT; Kim HT; Li S; Hochberg EP; Cutler C; Lee SJ; Fisher DC; Milford E; Kao G; Daley H; Levin J; Ng A; Mauch P; Alyea EP; Antin JH; Soiffer RJ
    Bone Marrow Transplant; 2004 Dec; 34(11):987-94. PubMed ID: 15489873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of GvHD by suicide-gene transduced donor T lymphocytes: clinical applications in mismatched transplantation.
    Ciceri F; Bonini C; Gallo-Stampino C; Bordignon C
    Cytotherapy; 2005; 7(2):144-9. PubMed ID: 16040393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
    Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
    Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors.
    Koh LP; Rizzieri DA; Chao NJ
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1249-67. PubMed ID: 17950913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to graft engineering for haploidentical bone marrow transplantation.
    Handgretinger R
    Semin Oncol; 2012 Dec; 39(6):664-73. PubMed ID: 23206843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation.
    Ruggeri L; Mancusi A; Burchielli E; Capanni M; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
    Blood Cells Mol Dis; 2008; 40(1):84-90. PubMed ID: 17964828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving immune reconstitution while preventing GvHD in allogeneic stem cell transplantation.
    André-Schmutz I; Dal Cortivo L; Fischer A; Cavazzana-Calvo M
    Cytotherapy; 2005; 7(2):102-8. PubMed ID: 16040389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation.
    Bastien JP; Roy J; Roy DC
    Semin Oncol; 2012 Dec; 39(6):674-82. PubMed ID: 23206844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin.
    Michálek J; Collins RH; Vitetta ES
    Neoplasma; 2003; 50(4):296-9. PubMed ID: 12937844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective elimination of alloreactivity from immunotherapeutic T cells by photodynamic cell purging and memory T-cell sorting.
    Le NT; Chen BJ; Chao NJ
    Cytotherapy; 2005; 7(2):126-33. PubMed ID: 16040391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
    Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
    Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
    Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
    Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity.
    Aversa F; Martelli MF; Velardi A
    Semin Oncol; 2012 Dec; 39(6):643-52. PubMed ID: 23206841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transplantation of highly purified CD34+ hematologic peripheral stem cells from haploidentical related donors in the treatment of children with non-malignant diseases].
    Starý J; Sedlácek P; Vodvárková S; Poloucková A; Formánková R; Gasová Z; Marinov I
    Cas Lek Cesk; 2002 Mar; 141(6):176-81. PubMed ID: 11977835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency.
    Martín-Hernández MP; Arrieta R; Martínez A; García P; Jimenez-Yuste V; Hernandez-Navarro F
    Bone Marrow Transplant; 1997 Nov; 20(9):797-9. PubMed ID: 9384486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.
    Bashey A; Solomon SR
    Bone Marrow Transplant; 2014 Aug; 49(8):999-1008. PubMed ID: 24842530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.